Showing results (11-20 of 198) with videos related to
Sort By:
Pageof 20
Current Pharmaceutical Design|February 7, 2003
Role of DAP12 in innate and adaptive immune responsesNaoko Aoki, Shoji Kimura, Zhou XingVaccine|July 20, 2002
Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulationJun Wang, Anna Zganiacz, Zhou XingViral Immunology|July 23, 2005
Adenoviral vectors for mucosal vaccination against infectious diseasesMichael Santosuosso, Sarah McCormick, Zhou XingChest|September 3, 2014
New approaches to TB vaccinationZhou Xing, Mangalakumari Jeyanathan, Fiona SmaillJournal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatisHang Lu, Zhou Xing, Robert C BrunhamExpert Review of Vaccines|December 14, 2011
A novel genetically engineered Mycobacterium smegmatis-based vaccine promotes anti-TB immunityMangalakumari Jeyanathan, Niroshan Thanthrige-Don, Zhou XingExpert Review of Respiratory Medicine|February 26, 2011
Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapySarah McCormick, Christopher R Shaler, Zhou XingInfection and Immunity|December 23, 2003
Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosisLihao Chen, Jun Wang, Anna Zganiacz, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Dendritic cells derived from murine colonic mucosa have unique functional and phenotypic characteristicsShunsuke Takenaka, Ekaterina Safroneeva, Zhou Xing, et al.Current Opinion in Immunology|July 27, 2023
Viral-vectored respiratory mucosal vaccine strategiesMangalakumari Jeyanathan, Sam Afkhami, Alisha Kang, et al.Pageof 20